Shareholder Votes

Coupang, Inc. shareholders approved Ratification of appointment of Samil PricewaterhouseCoopers as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-11 meeting.

“2.The appointment of Samil PricewaterhouseCoopers as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified by the vote set forth below: For Against Abstain Broker Non-Votes 5,651,854,104 25,805,924 260,643 N/A”

Coupang, Inc. shareholders approved Election of directors at the 2026-06-11 meeting.

“1.The following nominees were elected as directors, each to hold office until the Company’s next annual meeting of stockholders to be held in 2027, or until their successor is duly elected and qualified, by the vote set forth below: For Against Abstain Broker Non-Votes Bom Kim 5,469,716,106 123,989,238 202,537 84,012,790 Jason Child 5,429,964,562 163,683,412 259,907 84,012,790 Pedro Franceschi 5,579,365,035 14,273,823 269,023 84,012,790 Neil Mehta 5,583,181,119 10,472,310 254,452 84,012,790 Asha Sharma 5,573,562,381 20,075,988 269,512 84,012,790 Benjamin Sun 5,562,960,440 30,704,149 243,292 84,012,790 Ambereen Toubassy 5,408,990,607 184,685,050 232,224 84,012,790”

TARGET CORP shareholders rejected Shareholder proposal requesting a report on reducing plastic microfiber shedding at the 2026-06-10 meeting.

“The shareholders did not approve a shareholder proposal requesting a report on reducing plastic microfiber shedding: For: Shares 62,007,169 % 18.4 Against: Shares 270,654,883 % 80.3 Abstain: Shares 4,330,124 % 1.3 Broker Non-Votes: Shares 55,551,812”

TARGET CORP shareholders rejected Shareholder proposal requesting a report on presence of pesticides in Target's private label brands at the 2026-06-10 meeting.

“The shareholders did not approve a shareholder proposal requesting a report on presence of pesticides in Target’s private label brands: For: Shares 56,984,003 % 16.9 Against: Shares 275,003,485 % 81.6 Abstain: Shares 5,004,688 % 1.5 Broker Non-Votes: Shares 55,551,812”

TARGET CORP shareholders rejected Shareholder proposal requesting a policy requiring the Board Chair to be an independent director at the 2026-06-10 meeting.

“The shareholders did not approve a shareholder proposal requesting a policy requiring the Board Chair to be an independent director: For: Shares 128,544,372 % 38.1 Against: Shares 206,796,796 % 61.4 Abstain: Shares 1,651,008 % 0.5 Broker Non-Votes: Shares 55,551,812”

TARGET CORP shareholders approved Approval of Amended and Restated Target Corporation 2020 Long-Term Incentive Plan at the 2026-06-10 meeting.

“The shareholders approved the Amended and Restated Target Corporation 2020 Long-Term Incentive Plan: For: Shares 320,173,395 % 95.0 Against: Shares 14,595,917 % 4.3 Abstain: Shares 2,222,864 % 0.7 Broker Non-Votes: Shares 55,551,812”

TARGET CORP shareholders approved Advisory approval of executive compensation at the 2026-06-10 meeting.

“The shareholders approved, on an advisory basis, the Company’s executive compensation: For: Shares 298,234,525 % 89.0 Against: Shares 36,795,522 % 11.0 Abstain: Shares 1,962,129 Broker Non-Votes: Shares 55,551,812”

TARGET CORP shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal 2026 at the 2026-06-10 meeting.

“The shareholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for fiscal 2026: For: Shares 366,896,337 % 93.5 Against: Shares 24,917,538 % 6.3 Abstain: Shares 730,113 % 0.2”

TARGET CORP shareholders approved Election of twelve directors for a one-year term at the 2026-06-10 meeting.

“The shareholders elected twelve nominees as directors for a one-year term: For Against Broker Nominee Shares % Shares % Abstain Non-Votes David P. Abney 327,624,367 97.5 8,496,692 2.5 871,117 55,551,812 George S. Barrett 302,029,550 89.9 34,062,789 10.1 899,837 55,551,812 Gail K. Boudreaux 325,913,152 97.0 10,068,744 3.0 1,010,280 55,551,812 Stephen B. Bratspies 330,492,945 98.3 5,661,291 1.7 837,940 55,551,812 Brian C. Cornell 292,419,953 87.2 43,104,768 12.8 1,467,455 55,551,812 Robert L. Edwards 326,841,941 97.2 9,295,589 2.8 854,646 55,551,812 Michael J. Fiddelke 333,039,464 99.1 3,038,231 0.9 914,481 55,551,812 John R. Hoke III 332,129,244 98.8 4,015,335 1.2 847,597 55,551,812 Christine A. Leahy 297,685,712 88.5 38,569,015 11.5 737,449 55,551,812 Monica C. Lozano 319,957,287 95.2 16,084,623 4.8 950,266 55,551,812 Derica W. Rice 324,581,603 96.5 11,603,952 3.5 806,621 55,551,812 Dmitri L. Stockton 320,705,042 95.5 15,285,485 4.5 1,001,649 55,551,812”

908 Devices Inc. shareholders approved Advisory vote on the frequency of future advisory votes on the compensation of the Company’s named executive officers at the 2026-06-11 meeting.

“Proposal No. 4: Advisory vote on the frequency of future advisory votes”

908 Devices Inc. shareholders approved Advisory vote on the compensation of the Company’s named executive officers at the 2026-06-11 meeting.

“Proposal No. 3: Advisory vote on the compensation of the Company’s named executive officers”

908 Devices Inc. shareholders approved Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-11 meeting.

“Proposal No. 2: Ratification of the appointment of PricewaterhouseCoopers LLP”

908 Devices Inc. shareholders approved Election of Class III Directors at the 2026-06-11 meeting.

“Proposal No. 1: Election of Class III Directors.”

Medline Inc. shareholders approved Ratification of the Selection of Ernst & Young LLP as Independent Auditor for Fiscal Year 2026 at the 2026-06-11 meeting.

“Stockholders ratified the selection of Ernst & Young LLP as the Company’s independent auditor for fiscal year 2026 as follows:”

Medline Inc. shareholders approved Advisory Vote on the Frequency of Votes on Executive Compensation at the 2026-06-11 meeting.

“Stockholders approved, on an advisory basis, a frequency of one year for future advisory votes on the Company’s executive compensation as follows:”

Medline Inc. shareholders approved Advisory Vote to Approve Executive Compensation at the 2026-06-11 meeting.

“Stockholders approved, on an advisory basis, the Company’s executive compensation as follows:”

Medline Inc. shareholders approved Election of 12 director nominees named in the proxy statement at the 2026-06-11 meeting.

“Stockholders elected each of the 12 nominees to serve as a director of the Company for a one-year term expiring at the Company’s 2027 Annual Meeting of Stockholders as follows:”

ETSY INC shareholders rejected Advisory Vote on Stockholder Proposal to Govern by Majority Vote at the 2026-06-09 meeting.

“Stockholders rejected a stockholder proposal to govern by majority vote”

ETSY INC shareholders approved Approve an Amendment to Etsy's 2024 Equity Incentive Plan to Increase the Number of Shares of Common Stock Available for Issuance at the 2026-06-09 meeting.

“Stockholders approved an amendment to Etsy's 2024 Equity Incentive Plan.”

ETSY INC shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2026-06-09 meeting.

“Stockholders ratified the appointment of PricewaterhouseCoopers LLP as Etsy’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

ETSY INC shareholders approved Advisory Vote on Named Executive Officer Compensation at the 2026-06-09 meeting.

“Stockholders approved, on an advisory basis, the compensation of Etsy's named executive officers.”

ETSY INC shareholders approved Election of Class II Directors at the 2026-06-09 meeting.

“Each of the Class II director nominees to the Board of Directors was elected to serve until Etsy's 2029 Annual Meeting of Stockholders and until his or her successor has been elected and qualified or until he or she resigns, dies, or is removed from the Board of Directors.”

Whitehawk Therapeutics, Inc. shareholders approved Ratification of BDO USA, P.C. as independent registered public accounting firm at the 2026-06-11 meeting.

“Ratification of the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. For Against Abstentions 34,795,850 1,148,282 4,430,891”

Whitehawk Therapeutics, Inc. shareholders approved Advisory vote on executive compensation at the 2026-06-11 meeting.

“Proposal 2: To approve, on an advisory basis, the compensation of the named executive officers identified in the 2025 Summary Compensation Table in the “Executive Compensation” section of the Proxy Statement. For Against Abstentions Broker Non-Votes 22,896,061 6,013,600 3,623,688 7,841,674”

Whitehawk Therapeutics, Inc. shareholders approved Election of three Class III directors at the 2026-06-11 meeting.

“Behzad Aghazadeh, Ph.D. 26,666,124 5,867,225 7,841,674 Richard Maroun 27,701,332 4,832,017 7,841,674 Emma Reeve 27,704,564 4,828,785 7,841,674”

Evolus, Inc. shareholders approved Advisory approval of named executive officer compensation at the 2026-06-11 meeting.

“The stockholders of the Company approved, on an advisory basis, the compensation of the Company’s named executive officers.”

Evolus, Inc. shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm for year ending December 31, 2026 at the 2026-06-11 meeting.

“The stockholders of the Company ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026.”

Evolus, Inc. shareholders approved Election of Directors at the 2026-06-11 meeting.

“The stockholders of the Company elected each of Brady Stewart and Vikram Malik as Class II directors for a three-year term ending at the Annual Meeting of Stockholders to be held in 2029 and until each of their successors has been duly elected and qualified, or until their earlier death, resignation or removal.”

Resolute Holdings Management, Inc. shareholders approved Election of four Class II directors to serve until 2029 annual meeting. at the 2026-06-11 meeting.

“At the Annual Meeting, (i) the four (4) Class II directors were elected, and (ii) the Auditor Ratification Proposal was approved.”

Hagerty, Inc. shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for year ending December 31, 2026 at the 2026-06-09 meeting.

“The Company's stockholders ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.”

Hagerty, Inc. shareholders approved Advisory Vote on the Frequency of Future Advisory Votes on the Compensation of the Company’s Named Executive Officers at the 2026-06-09 meeting.

“The Company’s stockholders recommended, on a non-binding advisory basis, that future advisory votes on the compensation of the Company’s named executive officers be held every one year.”

Hagerty, Inc. shareholders approved Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers at the 2026-06-09 meeting.

“The Company’s stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed in the Company’s proxy statement.”

Hagerty, Inc. shareholders approved Election of Directors at the 2026-06-09 meeting.

“Each of the following directors received the affirmative vote of a majority of the votes cast at the Annual Meeting at which a quorum was present, and were elected for a one-year term expiring at the Company's 2027 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified.”

BKV Corp shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-11 meeting.

“Proposal 2 : The Company’s stockholders approved the ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

BKV Corp shareholders approved Election of Class II directors at the 2026-06-11 meeting.

“Proposal 1 : The Company’s stockholders elected to the board of directors of the Company each of the following Class II director nominees to serve until the 2029 annual meeting of stockholders.”

Krispy Kreme, Inc. shareholders approved Approval of Amendment and Restatement of the Company’s 2021 Omnibus Incentive Plan at the 2026-06-10 meeting.

“Proposal 4: Approval of Amendment and Restatement of the Company’s 2021 Omnibus Incentive Plan The Company’s stockholders approved the Amendment and Restatement of the Krispy Kreme, Inc. 2021 Omnibus Incentive Plan.”

Krispy Kreme, Inc. shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2026-06-10 meeting.

“Proposal 3: Ratification of the Appointment of Independent Registered Public Accounting Firm The Company’s stockholders ratified the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for fiscal year 2026.”

Krispy Kreme, Inc. shareholders approved Advisory Resolution to Approve Executive Compensation at the 2026-06-10 meeting.

“Proposal 2: Advisory Resolution to Approve Executive Compensation The Company’s stockholders approved an advisory resolution regarding the Company’s executive compensation.”

Krispy Kreme, Inc. shareholders approved Election of Directors at the 2026-06-10 meeting.

“Proposal 1: Election of Directors The Company’s stockholders elected eight directors to hold office for a one-year term and until his or her successor shall have been elected and qualified.”

TheRealReal, Inc. shareholders rejected Approval of a Management Proposal to Amend the Company’s Amended and Restated Certificate of Incorporation to Eliminate the Supermajority Voting Requirements at the 2026-06-10 meeting.

“The Company’s stockholders did not approve by a supermajority of the Company’s outstanding shares a management proposal to amend the Company’s Amended and Restated Certificate of Incorporation to eliminate the supermajority voting requirements.”

TheRealReal, Inc. shareholders rejected Approval of a Management Proposal to Amend the Company’s Amended and Restated Certificate of Incorporation to Limit the Liability of Certain Officers of the Company as Permitted Pursuant to the Delaware General Corporation Law at the 2026-06-10 meeting.

“The Company’s stockholders did not approve by a supermajority of the Company’s outstanding shares a management proposal to amend the Company’s Amended and Restated Certificate of Incorporation to limit the liability of certain officers of the Company as permitted pursuant to the Delaware General Corporation Law.”

TheRealReal, Inc. shareholders rejected Approval of a Management Proposal to Amend the Company’s Amended and Restated Certificate of Incorporation to Phase in the Declassification of our Board of Directors at the 2026-06-10 meeting.

“The Company’s stockholders did not approve by a supermajority of the Company’s outstanding shares a management proposal to amend the Company’s Amended and Restated Certificate of Incorporation to phase in the declassification of the Company’s Board of Directors.”

TheRealReal, Inc. shareholders approved Advisory Vote on Named Executive Officer Compensation at the 2026-06-10 meeting.

“The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers.”

TheRealReal, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-10 meeting.

“The Company’s stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

TheRealReal, Inc. shareholders approved Election of Class I Directors at the 2026-06-10 meeting.

“The Company’s stockholders elected each of the nominees named below as Class I directors to serve a three-year term ending at the Company’s 2029 annual meeting of stockholders or until his or her successor is elected and qualified.”

Annexon, Inc. shareholders approved Amendment to certificate of incorporation to increase authorized shares from 300,000,000 to 500,000,000 at the 2026-06-11 meeting.

“The approval of an amendment to the Company’s amended and restated certificate of incorporation to increase the number of authorized shares of common stock from 300,000,000 to 500,000,000. For Against Abstain Broker Non-Votes 129,051,256 4,374,799 8,795,454 —”

Annexon, Inc. shareholders approved Advisory (non-binding) approval of named executive officer compensation at the 2026-06-11 meeting.

“The approval, on an advisory (non-binding) basis, of the compensation of the Company’s named executive officers. For Against Abstain Broker Non-Votes 122,347,513 1,986,387 68,794 17,818,815”

Annexon, Inc. shareholders approved Ratification of KPMG LLP as independent registered public accounting firm at the 2026-06-11 meeting.

“The ratification of the selection by the Audit Committee of our Board of Directors of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The selection was ratified by the votes indicated. For Against Abstain Broker Non-Votes 142,016,122 185,546 19,841 —”

Annexon, Inc. shareholders approved Election of Class III directors at the 2026-06-11 meeting.

“The following two Class III directors were elected by the votes indicated. For Withheld Broker Non-Votes Bettina M. Cockroft, M.D. 101,594,745 22,807,949 17,818,815 Douglas Love, Esq. 107,491,451 16,911,243 17,818,815”

Citi Trends Inc shareholders approved Ratification, on a non-binding basis, of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending January 30, 2027 at the 2026-06-10 meeting.

“(3) Ratification, on a non-binding basis, of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending January 30, 2027: For Against Abstain Broker Non-Votes 7,311,711 1,301 8,318 0”